GSK completes production-line upgrade; U.K. to boost Big Pharma appeal;

> GlaxoSmithKline ($GSK) has completed a three-year, $7-million upgrade of two production lines at a plant in Brasov, Romania. Item

> BioMarin Pharmaceutical will double the capacity of its Novato, CA, plant to produce $1 billion in products, including biggest seller Naglazyme. Item

> Six drug-delivery technologies are helping drugmakers extend patents: affinity-based targeting, controlled/sustained-release systems, passive delivery, active device delivery, passive device delivery and processing technologies. Release

> Tanzania is set to begin production of generic antiretroviral drugs in a new multi-million-dollar manufacturing plant in Arusha. Story

> Vivimed Labs of Hyderabad, India, has acquired Uquifa, a manufacturer of APIs and intermediates with operations in Spain and Mexico. Article

> Norbert Dentressangle has opened a shared-user cold store facility in the south of France. Story

> A groundbreaking ceremony on Friday signaled the construction start of a $394 million Chengdu, Sichuan, China cold-chain logistics center, which will boast 160,000 square meters of distribution space. Article

> The U.K.'s FDS Pharma has acquired the Rehovot hepatitis vaccine manufacturing plant of SciGen Israel for $2 million plus 5% royalties on sales. Story

> Millstone Medical Outsourcing said it will provide freezer storage and cold chain distribution services for customers' biologic products from a Memphis, TN-based facility. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.